(Q34818576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

1 reference

acute myeloid leukemia

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Ke Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Xiao-Xi Lv

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fang Hua

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Heng Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Wen-Bin Cao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Xiao-Ming Fu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jing Xie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jiao-Jiao Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zhe Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hong Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ming-Zhe Han

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Zhuo-Wei Hu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

10 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

692-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

Molecular action of lenalidomide in lymphocytes and hematologic malignancies

5 March 2020

cites work

1 reference

Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation

21 January 2018

1 reference

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

21 January 2018

1 reference

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

21 January 2018

1 reference

Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization

21 January 2018

1 reference

Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia

21 January 2018

1 reference

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

21 January 2018

1 reference

Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways

21 January 2018

1 reference

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

21 January 2018

1 reference

Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity

21 January 2018

1 reference

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

21 January 2018

1 reference

Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements

21 January 2018

1 reference

Cell-penetrating peptides as a novel transdermal drug delivery system

21 January 2018

1 reference

Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides

21 January 2018

1 reference

Mechanisms of cellular uptake of cell-penetrating peptides

21 January 2018

1 reference

siRNA delivery: from lipids to cell-penetrating peptides and their mimics

21 January 2018

1 reference

Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells

21 January 2018

1 reference

Leukemia-targeting ligands isolated from phage-display peptide libraries.

21 January 2018

1 reference

TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity

21 January 2018

1 reference

The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases.

21 January 2018

1 reference

STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation.

21 January 2018

1 reference

Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions.

21 January 2018

1 reference

Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer

21 January 2018

1 reference

Blocking TLR2 activity attenuates pulmonary metastases of tumor

21 January 2018

1 reference

Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.

21 January 2018

1 reference

De novo antimicrobial peptides with low mammalian cell toxicity

21 January 2018

1 reference

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide

21 January 2018

1 reference

Biopanning and rapid analysis of selective interactive ligands

21 January 2018

1 reference

Targeting neuropilin-1 in human leukemia and lymphoma

21 January 2018

1 reference

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients

21 January 2018

1 reference

The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy

21 January 2018

1 reference

Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.

21 January 2018

1 reference

Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.

21 January 2018

1 reference

Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function

21 January 2018

1 reference

Mycobacterium tuberculosis Lipoproteins Directly Regulate Human Memory CD4 + T Cell Activation via Toll-Like Receptors 1 and 2

21 January 2018

1 reference

Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

21 January 2018

1 reference

A permease-like protein involved in ER to thylakoid lipid transfer in Arabidopsis

21 January 2018

1 reference

Mitochondria as therapeutic targets for cancer chemotherapy

21 January 2018

1 reference

Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23852533%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference